Depreciation of Protalix BioTherapeutics, Inc. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protalix BioTherapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • Protalix BioTherapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $346,000, a 7.5% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2024 was $1,304,000, a 9.5% increase from 2023.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2023 was $1,191,000, a 9.7% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2022 was $1,086,000, a 2.9% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Protalix BioTherapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $346,000 +$24,000 +7.5% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $322,000 +$42,000 +15% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $280,000 +$10,000 +3.7% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $270,000 -$16,000 -5.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $286,000 -$90,000 -24% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $376,000 -$29,000 -7.2% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2019 $405,000 -$25,000 -5.8% 01 Jan 2019 31 Mar 2019 10-Q 01 Jun 2020 2020 Q1
Q1 2018 $430,000 -$62,000 -13% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $492,000 -$24,000 -4.7% 01 Jan 2017 31 Mar 2017 10-Q 18 Mar 2019 2018 Q1
Q1 2016 $516,000 -$100,000 -16% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $616,000 -$212,000 -26% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $828,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1

Protalix BioTherapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,304,000 +$113,000 +9.5% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $1,191,000 +$105,000 +9.7% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $1,086,000 -$32,000 -2.9% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $1,118,000 -$184,000 -14% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $1,302,000 -$315,000 -19% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $1,617,000 -$54,000 -3.2% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
2018 $1,671,000 -$249,000 -13% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2021 2020 FY
2017 $1,920,000 -$63,000 -3.2% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $1,983,000 -$387,000 -16% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $2,370,000 -$770,000 -25% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
2014 $3,140,000 -$399,000 -11% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $3,539,000 -$153,000 -4.1% 01 Jan 2013 31 Dec 2013 10-K 08 Mar 2016 2015 FY
2012 $3,692,000 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.